drugset / Trial / NCT06379893

A Real-World Evidence Study to Evaluate the Effects of Voltaren Use on Mobility and Quality of Life in Participants With Knee Osteoarthritis Pain

NCT06379893 ↗

Phase 4 Completed 196 enrolled HALEON
NaSingle-groupOpen-labelTreatment

Summary

The purpose of this study is to investigate how topical diclofenac use can improve functional mobility and physical activity primarily, as well as other quality-of-life (QoL) parameters such as sleep, mood, and engagement in daily activities in participants with knee OA.

Timeline

Start
2024-04-25
Primary completion
2024-10-29
Completion
2024-10-29

Outcome

Mixed primary results

registry A positive change from Baseline indicated improvement. NCT06379893 ↗

registry analysis (superiority test); Voltaren Gel; p <0.001; Least Square Means 15.6 (95% CI 8.3 to 22.8); MMRM NCT06379893 ↗

registry analysis (superiority test); Voltaren Gel; p = 0.001; Least Square Means 13 (95% CI 5.2 to 20.9); MMRM NCT06379893 ↗

registry analysis (superiority test); Voltaren Gel; p = 0.653; Least Square Means 2.1 (95% CI -7.1 to 11.3); MMRM NCT06379893 ↗

Drugs

EvaluationDrugModalityDoseRoute
Subject Diclofenac Other / unclassified 1 % Topical
Subject Diclofenac Other / unclassified 1.16 % Topical
Subject Diclofenac Other / unclassified 2.32 % Topical

Indications

No indication recorded.